DILI-话题@MedSci

#DILI#

2篇内容 | 1225人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2246279, encodeId=533b22462e986, content=<a href='/topic/show?id=bac8100834b5' target=_blank style='color:#2F92EE;'>#风湿病#</a> <a href='/topic/show?id=f980596e42' target=_blank style='color:#2F92EE;'>#DILI#</a>, objectTitle=茅益民教授：当风湿病遇到DILI, objectType=article, longId=857865, objectId=3f9e85e865a6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240530/1717054869962_5579292.jpg, objectUrl=/article/show_article.do?id=3f9e85e865a6, replyNumber=0, likeNumber=11, createdTime=2025-01-02, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=3f9e85e865a6, moduleTitle=茅益民教授：当风湿病遇到DILI, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f9e85e865a6)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2243603, encodeId=bfa122436031a, content=<a href='/topic/show?id=802b8e74083' target=_blank style='color:#2F92EE;'>#药物性肝损伤#</a> <a href='/topic/show?id=f980596e42' target=_blank style='color:#2F92EE;'>#DILI#</a>, objectTitle=陈成伟教授专访 | DILI：知易行难，如何填补认知与实践的鸿沟？, objectType=article, longId=855997, objectId=338b85599eee, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241127/1732690218078_8538692.jpg, objectUrl=/article/show_article.do?id=338b85599eee, replyNumber=0, likeNumber=19, createdTime=2024-12-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=338b85599eee, moduleTitle=陈成伟教授专访 | DILI：知易行难，如何填补认知与实践的鸿沟？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=338b85599eee)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1495784, encodeId=75391495e847e, content=<a href='/topic/show?id=f980596e42' target=_blank style='color:#2F92EE;'>#DILI#</a>, objectTitle=药物性肝损伤(DILI)诊断：RUCAM量表与结构性专家诊断程序争鸣, objectType=article, longId=32962, objectId=d813329623c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d813329623c, replyNumber=0, likeNumber=65, createdTime=2014-04-09, rootId=0, userName=mhm292, userId=6da79200098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d813329623c, moduleTitle=药物性肝损伤(DILI)诊断：RUCAM量表与结构性专家诊断程序争鸣, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d813329623c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1495783, encodeId=7e8a1495e8358, content=<a href='/topic/show?id=f980596e42' target=_blank style='color:#2F92EE;'>#DILI#</a>, objectTitle=Lancet Oncol：Pidilizumab联合利妥昔单抗治疗复发性滤泡状淋巴瘤疗效显著, objectType=article, longId=28792, objectId=8dfe28e926c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8dfe28e926c, replyNumber=0, likeNumber=75, createdTime=2014-01-03, rootId=0, userName=mhm292, userId=6da79200098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8dfe28e926c, moduleTitle=Lancet Oncol：Pidilizumab联合利妥昔单抗治疗复发性滤泡状淋巴瘤疗效显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8dfe28e926c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

DILI

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#风湿病# #DILI#

茅益民教授：当风湿病遇到DILI

2025-01-02发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#药物性肝损伤# #DILI#

陈成伟教授专访 | DILI：知易行难，如何填补认知与实践的鸿沟？

2024-12-19发表于陕西省

mhm292 (审核中...)

前往app查看评论内容

#DILI#

药物性肝损伤(DILI)诊断：RUCAM量表与结构性专家诊断程序争鸣

2014-04-09

mhm292 (审核中...)

前往app查看评论内容

#DILI#

Lancet Oncol：Pidilizumab联合利妥昔单抗治疗复发性滤泡状淋巴瘤疗效显著

2014-01-03

科室
- - 订阅+
  - 更多科室
工具
服务